Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Agency Clears BGI-Complete Genomics Deal

NEW YORK (GenomeWeb News) – The Ministry of Commerce of the People's Republic of China has approved BGI's proposed acquisition of Complete Genomics, BGI announced after the close of the market on Monday.

The $118 million deal is still awaiting approval by the China's State Administration of Foreign Exchange. BGI last week extended its cash tender offer for Complete Genomics until midnight ET March 1, as it waited for approval from the two agencies.

BGI's bid for the Mountain View, Calif.-based firm was originally announced in September. The deal cleared US antitrust review in early January.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.